Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-005104
Filing Date
2020-04-24
Accepted
2020-04-24 18:11:56
Documents
1
Period of Report
2020-04-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6912
  Complete submission text file 0001179110-20-005104.txt   8334
Mailing Address 600 LEE ROAD SUITE 100 WAYNE PA 19087
Business Address 600 LEE ROAD SUITE 100 WAYNE PA 19087 610-833-4200
Zyla Life Sciences (Issuer) CIK: 0001586105 (see all company filings)

EIN.: 463575334 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 MANHATTANVILLE ROAD SUITE 201 PURCHASE NY 10577
Business Address
McInnis Joe (Reporting) CIK: 0001588987 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36295 | Film No.: 20816431